Literature DB >> 17482134

Rewired ERK-JNK signaling pathways in melanoma.

Pablo Lopez-Bergami1, Conway Huang, James S Goydos, Dana Yip, Menashe Bar-Eli, Meenhard Herlyn, Keiran S M Smalley, Alka Mahale, Alexey Eroshkin, Stuart Aaronson, Ze'ev Ronai.   

Abstract

Constitutive activation of MEK-ERK signaling is often found in melanomas. Here, we identify a mechanism that links ERK with JNK signaling in human melanoma. Constitutively active ERK increases c-Jun transcription and stability, which are mediated by CREB and GSK3, respectively. Subsequently, c-Jun increases transcription of target genes, including RACK1, an adaptor protein that enables PKC to phosphorylate and enhance JNK activity, enforcing a feed-forward mechanism of the JNK-Jun pathway. Activated c-Jun is also responsible for elevated cyclin D1 expression, which is frequently overexpressed in human melanoma. Our data reveal that, in human melanoma, the rewired ERK signaling pathway upregulates JNK and activates the c-Jun oncogene and its downstream targets, including RACK1 and cyclin D1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482134      PMCID: PMC1978100          DOI: 10.1016/j.ccr.2007.03.009

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  55 in total

Review 1.  Signal transduction by the JNK group of MAP kinases.

Authors:  R J Davis
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Adaptor proteins in protein kinase C-mediated signal transduction.

Authors:  D Schechtman; D Mochly-Rosen
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

3.  MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts.

Authors:  Giselle R Wiggin; Ana Soloaga; Julia M Foster; Victoria Murray-Tait; Philip Cohen; J Simon C Arthur
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 4.  Jun, the oncoprotein.

Authors:  P K Vogt
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

5.  Cyclin D1 is a candidate oncogene in cutaneous melanoma.

Authors:  Edward R Sauter; Un-Cheol Yeo; Andrea von Stemm; Weizhu Zhu; Samuel Litwin; David S Tichansky; Giuseppa Pistritto; Mark Nesbit; Dan Pinkel; Meenhard Herlyn; Boris C Bastian
Journal:  Cancer Res       Date:  2002-06-01       Impact factor: 12.701

6.  Cooperation between STAT3 and c-jun suppresses Fas transcription.

Authors:  V N Ivanov; A Bhoumik; M Krasilnikov; R Raz; L B Owen-Schaub; D Levy; C M Horvath; Z Ronai
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

Review 7.  AP-1 as a regulator of cell life and death.

Authors:  Eitan Shaulian; Michael Karin
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

Review 8.  The JNK signal transduction pathway.

Authors:  Claire R Weston; Roger J Davis
Journal:  Curr Opin Genet Dev       Date:  2002-02       Impact factor: 5.578

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.

Authors:  G M Maelandsmo; V A Flørenes; E Hovig; T Oyjord; O Engebraaten; R Holm; A L Børresen; O Fodstad
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

View more
  124 in total

Review 1.  Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail.

Authors:  Gajanan S Inamdar; SubbaRao V Madhunapantula; Gavin P Robertson
Journal:  Biochem Pharmacol       Date:  2010-05-09       Impact factor: 5.858

2.  The RNA-binding protein SERBP1 interacts selectively with the signaling protein RACK1.

Authors:  Graeme B Bolger
Journal:  Cell Signal       Date:  2017-03-04       Impact factor: 4.315

Review 3.  Working hard at the nexus between cell signaling and the ribosomal machinery: An insight into the roles of RACK1 in translational regulation.

Authors:  Simone Gallo; Nicola Manfrini
Journal:  Translation (Austin)       Date:  2015-11-23

4.  COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis.

Authors:  Jing Shao; Yong Teng; Ravi Padia; Sungguan Hong; Hyangsoon Noh; Xiayang Xie; Jeff S Mumm; Zheng Dong; Han-Fei Ding; John Cowell; Jaejik Kim; Jiahuai Han; Shuang Huang
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

5.  Mycosporine-like amino acids stimulate hyaluronan secretion by up-regulating hyaluronan synthase 2 via activation of the p38/MSK1/CREB/c-Fos/AP-1 axis.

Authors:  Shuko Terazawa; Masahiko Nakano; Akio Yamamoto; Genji Imokawa
Journal:  J Biol Chem       Date:  2020-04-13       Impact factor: 5.157

6.  Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer.

Authors:  Luping Lin; Saurabh Asthana; Elton Chan; Sourav Bandyopadhyay; Maria M Martins; Victor Olivas; Jenny Jiacheng Yan; Luu Pham; Mingxue Michelle Wang; Gideon Bollag; David B Solit; Eric A Collisson; Charles M Rudin; Barry S Taylor; Trever G Bivona
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

7.  Expression of Death Receptor 4 Is Positively Regulated by MEK/ERK/AP-1 Signaling and Suppressed upon MEK Inhibition.

Authors:  Weilong Yao; You-Take Oh; Jiusheng Deng; Ping Yue; Liang Deng; Henry Huang; Wei Zhou; Shi-Yong Sun
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

8.  The role of the c-Jun N-terminal Kinase signaling pathway in skin cancer.

Authors:  Jennifer Y Zhang; Maria Angelica Selim
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

9.  Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition.

Authors:  Andrea Rasola; Marco Sciacovelli; Federica Chiara; Boris Pantic; William S Brusilow; Paolo Bernardi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

10.  A novel role of IKKalpha in the mediation of UVB-induced G0/G1 cell cycle arrest response by suppressing Cyclin D1 expression.

Authors:  Lun Song; Wen Dong; Ming Gao; Jingxia Li; Meiru Hu; Ning Guo; Chuanshu Huang
Journal:  Biochim Biophys Acta       Date:  2010-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.